P1vital, a contract research organisation (CRO) based at Oxford University’s Department of Psychiatry in Warneford Hospital and specialising in experimental medicine for central nervous system (CNS) disorders and, has formed a ‘pre-competitive’ consortium with four pharmaceutical companies in the UK.
Read MoreCalifornia’s renowned Salk Institute for Biological Sciences has signed a memorandum of understanding with Ipsen, the French pharmaceutical company specialising in oncology, endocrinology and neuromuscular disorders, to set up an Ipsen Life Sciences Program at the US institute.
Read MoreUS-based contract research organisation Quintiles Transnational has consolidated and expanded its Global Central Laboratories and Clinical Development Services units in Beijing to accommodate a growing business in China.
Read MoreTwo German companies are the recipients of the first opinions on paediatric investigation plans (PIPs) adopted by the European Medicines Agency’s Paediatric Committee (PDCO).
Read MoreA drug safety test that uses thousands of laboratory mice and rats each year in Europe is no longer necessary, a review involving 18 pharmaceutical companies and contract research organisations has found.
Read More
